S&P 500   5,087.03 (+2.11%)
DOW   39,069.11 (+1.18%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
S&P 500   5,087.03 (+2.11%)
DOW   39,069.11 (+1.18%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
S&P 500   5,087.03 (+2.11%)
DOW   39,069.11 (+1.18%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
S&P 500   5,087.03 (+2.11%)
DOW   39,069.11 (+1.18%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)

Lipella Pharmaceuticals (LIPO) Earnings Date, Estimates & Call Transcripts

$1.00
-0.01 (-0.99%)
(As of 02/22/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

LIPO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LIPO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

LIPO Earnings Date and Information

Lipella Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 29th, 2024 based off prior year's report dates.

Lipella Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/29/2024
Estimated)
------- 
11/13/2023Q3 2023-($0.23)($0.23)($0.23)-$0.10 million
8/14/2023Q2 2023-($0.27)($0.27)($0.27)-$0.11 million
5/15/2023Q1 2023-($0.19)($0.19)($0.19)-$0.12 million












Lipella Pharmaceuticals Earnings - Frequently Asked Questions

When is Lipella Pharmaceuticals's earnings date?

Lipella Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 29th, 2024 based off last year's report dates. Learn more on LIPO's earnings history.

How much revenue does Lipella Pharmaceuticals generate each year?

Lipella Pharmaceuticals (NASDAQ:LIPO) has a recorded annual revenue of $180,000.00.

How much profit does Lipella Pharmaceuticals generate each year?

Lipella Pharmaceuticals (NASDAQ:LIPO) has a recorded net income of -$2.60 million. LIPO has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:LIPO) was last updated on 2/22/2024 by MarketBeat.com Staff